Stability of Ophthalmic Atropine Solutions for Child Myopia Control

Myopia is an ophthalmic condition affecting more than 1/5th of the world population, especially children. Low-dose atropine eyedrops have been shown to limit myopia evolution during treatment. However, there are currently no commercial industrial forms available and there is little data published co...

Descripción completa

Detalles Bibliográficos
Autores principales: Berton, Baptiste, Chennell, Philip, Yessaad, Mouloud, Bouattour, Yassine, Jouannet, Mireille, Wasiak, Mathieu, Sautou, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465901/
https://www.ncbi.nlm.nih.gov/pubmed/32824572
http://dx.doi.org/10.3390/pharmaceutics12080781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465901/
https://www.ncbi.nlm.nih.gov/pubmed/32824572
http://dx.doi.org/10.3390/pharmaceutics12080781

Ejemplares similares